{"demo.pdf": {"figures": [{"page": 2, "region_bb": [62, 637, 218, 96], "figure_type": "Figure", "page_width": 595, "page_height": 793, "caption_bb": [37, 740, 212, 16], "caption_text": ["Fig. 1. Percentage of global population aged 65 years or over according to the", "medium-variant projection (UN, 2019)."]}, {"page": 2, "region_bb": [347, 545, 166, 195], "figure_type": "Figure", "page_width": 595, "page_height": 793, "caption_bb": [329, 749, 184, 7], "caption_text": ["Fig. 2. Chemical structure of nicotinamide mononucleotide (NMN)."]}, {"page": 3, "region_bb": [312, 487, 238, 200], "figure_type": "Figure", "page_width": 595, "page_height": 793, "caption_bb": [306, 697, 226, 59], "caption_text": ["Fig. 3. NAD+ biosynthesis pathways in which NMN involves. Biosynthetic path-", "ways of NAD+ in mammalian cells in which NMN involves are Preiss\u2013Handler and", "salvage pathways, and the salvage pathway is the major source of NAD+. NAMPT-", "nicotinamide phosphoribosyltransferase; ATP-adenosine triphosphate; ADP-ade-", "nosine diphosphate; NMNAT-nicotinamide mononucleotide adenylyltransferase;", "NRK-nicotinamide riboside kinases; NAPRT-nicotinate phosphoribosyltransferase;", "NADS-nicotinamide adenine dinucleotide synthetases."]}, {"page": 4, "region_bb": [118, 361, 357, 351], "figure_type": "Figure", "page_width": 595, "page_height": 793, "caption_bb": [37, 723, 474, 33], "caption_text": ["Fig. 4. Causes for reducing NAD+ levels when aging and mechanism underlying anti-aging activity of NMN. DNA damage, chronic in\ufb02ammation, oxidative stress and", "increasing NAD+ consuming enzymes (sirtuins, CD38/CD157, PARP, TNKS and BST) accelerate NAD degradation. The reduced levels of NAD+ cause downregulation of energy", "production in mitochondria, leading to aging and various age-associated diseases. NMN supplementation can reinstate NAD+ levels in the body through biosynthesis", "pathways, reversing the aging process and preventing age-associated diseases."]}], "pages_annotated": [], "fig_no": 4}}